Additionally, as in all those studies, amenorrhea was considered a measure of ovarian function, while regular menses are not an appropriate marker of ovarian reserve.5,28,29 D’Avila et al7 followed a cohort of 52 BC patients and assessed AMH and AFC before and 6 months after receiving cyclophosphamide. The gene discussed is AMH; the disease is breast cancer.